GARM: Multifocal Contact Lens Use in Previous Contact Lens Wearers With Near Vision Demands

Sponsor
CIBA VISION (Industry)
Overall Status
Completed
CT.gov ID
NCT00965237
Collaborator
University of Waterloo (Other)
16
1
2
4
4

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate the use of a multifocal contact lens in people who previously wore contact lenses but discontinued due to age-related, near vision demands.

Condition or Disease Intervention/Treatment Phase
  • Device: lotrafilcon B multifocal contact lens
  • Device: lotrafilcon B single vision contact lens
  • Other: Over-reader spectacles
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
P/331/09/C: Multifocal Pilot Study: Refitting Drop Outs (GARM)
Study Start Date :
Aug 1, 2009
Actual Primary Completion Date :
Dec 1, 2009
Actual Study Completion Date :
Dec 1, 2009

Arms and Interventions

Arm Intervention/Treatment
Other: Multifocal CL / Single vision CL + reading glasses

Lotrafilcon B multifocal contact lenses (CL) worn first, with lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis.

Device: lotrafilcon B multifocal contact lens
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use

Device: lotrafilcon B single vision contact lens
Commercially marketed, silicone hydrogel, single vision contact lens for daily wear use

Other: Over-reader spectacles
Reading glasses worn over single vision contact lenses for near vision work on an as-needed basis

Other: Single vision CL + reading glasses / Multifocal CL

Lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn first, with lotrafilcon B multifocal contact lenses (CL) worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis.

Device: lotrafilcon B multifocal contact lens
Commercially marketed, silicone hydrogel, multifocal contact lens for daily wear use

Device: lotrafilcon B single vision contact lens
Commercially marketed, silicone hydrogel, single vision contact lens for daily wear use

Other: Over-reader spectacles
Reading glasses worn over single vision contact lenses for near vision work on an as-needed basis

Outcome Measures

Primary Outcome Measures

  1. Overall Satisfaction With the Lenses [1 week of wear]

    Overall satisfaction with the lenses was interpreted by and assessed by the subject as a single, retrospective measurement of one week's wear time. Overall satisfaction with the lenses was recorded on a questionnaire as a numerical rating on a scale of 1 to 100, with 1 being completely dissatisfied, and 100 being excellent, completely satisfied.

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • has discontinued contact lens wear primarily due to age-related, near vision demands

  • requires a reading add of +0.50 to +1.75 D (inclusive) and is correctable to at least 6/9 monocular, distance and near with spectacle correction

  • has had an ocular examination in the last 2 years

  • Other protocol-defined inclusion/exclusion criteria may apply

Exclusion Criteria:
  • has any ocular disease

  • has more than a 2.00D prescription difference between eyes

  • cannot be fit successfully with the study contact lenses

  • has any systemic disease affecting ocular health

  • is using any systemic or topical medications that may affect ocular health

  • has undergone corneal refractive surgery

  • Other protocol-defined inclusion/exclusion criteria may apply

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Waterloo Centre for Contact Lens Research Waterloo Ontario Canada N2L 3G1

Sponsors and Collaborators

  • CIBA VISION
  • University of Waterloo

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
CIBA VISION
ClinicalTrials.gov Identifier:
NCT00965237
Other Study ID Numbers:
  • P-368-C-101
First Posted:
Aug 25, 2009
Last Update Posted:
Jul 10, 2012
Last Verified:
Jan 1, 2012
Additional relevant MeSH terms:

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail
Arm/Group Title Multifocal CL / Single Vision CL+ Reading Glasses Single Vision CL + Reading Glasses / Multifocal CL
Arm/Group Description Lotrafilcon B multifocal contact lenses (CL) worn first, with lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis. Lotrafilcon B single vision contact lenses (CL) and over-reader spectacles worn first, with lotrafilcon B multifocal contact lenses (CL) worn second. Both contact lens products worn bilaterally on a daily wear basis; over-reader spectacles worn on an as-needed basis.
Period Title: Period 1, One Week of Wear
STARTED 8 8
COMPLETED 8 8
NOT COMPLETED 0 0
Period Title: Period 1, One Week of Wear
STARTED 8 8
COMPLETED 8 8
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title Overall Study
Arm/Group Description This reporting group includes all enrolled and dispensed subjects.
Overall Participants 16
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
48.3
(4.5)
Sex: Female, Male (Count of Participants)
Female
12
75%
Male
4
25%

Outcome Measures

1. Primary Outcome
Title Overall Satisfaction With the Lenses
Description Overall satisfaction with the lenses was interpreted by and assessed by the subject as a single, retrospective measurement of one week's wear time. Overall satisfaction with the lenses was recorded on a questionnaire as a numerical rating on a scale of 1 to 100, with 1 being completely dissatisfied, and 100 being excellent, completely satisfied.
Time Frame 1 week of wear

Outcome Measure Data

Analysis Population Description
Analysis conducted per protocol
Arm/Group Title Lotrafilcon B Multifocal Contact Lens Lotrafilcon B Single Vision Contact Lens + Reading Glasses
Arm/Group Description Commercially marketed, lotrafilcon B, silicone hydrogel, multifocal contact lens for daily wear use Commercially marketed, lotrafilcon B, silicone hydrogel, single vision contact lenses for daily wear use, with over-reader spectacles worn as needed
Measure Participants 16 16
Mean (Standard Deviation) [Units on a Scale]
82.5
(14.5)
64.4
(22.9)

Adverse Events

Time Frame Adverse event data were collected for the duration of the trial. Individual subject exposure = 1 week per product, total 2 weeks.
Adverse Event Reporting Description
Arm/Group Title Multifocal Contact Lens Single Vision Contact Lens
Arm/Group Description Commercially marketed lotrafilcon B multifocal contact lenses Commercially marketed lotrafilcon B single vision contact lenses
All Cause Mortality
Multifocal Contact Lens Single Vision Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total / (NaN) / (NaN)
Serious Adverse Events
Multifocal Contact Lens Single Vision Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/16 (0%) 0/16 (0%)
Other (Not Including Serious) Adverse Events
Multifocal Contact Lens Single Vision Contact Lens
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/16 (0%) 0/16 (0%)

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

No distribution of trial-specific information without express written permission of director.

Results Point of Contact

Name/Title Priya Janakiraman, OD, FAAO / Head, Global Clinical Affairs
Organization CIBA VISION
Phone 1-800-241-7629
Email priya.janakiraman@cibavision.com
Responsible Party:
CIBA VISION
ClinicalTrials.gov Identifier:
NCT00965237
Other Study ID Numbers:
  • P-368-C-101
First Posted:
Aug 25, 2009
Last Update Posted:
Jul 10, 2012
Last Verified:
Jan 1, 2012